Please login to the form below

Not currently logged in

Coronavirus disruption scuppers Curium Pharma sale


London-based private equity firm CapVest will wait for market to improve

Did Trump offer CureVac $1bn for COVID-19 vaccine rights?

Coronavirus vaccineMedia reports claim Trump administration tried to secure exclusive rights

Lilly joins new Medicare scheme to reduce insulin prices

Eli Lilly new HQNew model will cover seniors enrolled in Medicare Part D

Shionogi makes buyout play for Tetra ahead of Alzheimer’s readout

ShionogiPivotal mid-stage trial results due later this month

AbbVie says Allergan takeover delayed by FTC verdict

AbbVie buildingMerger now likely to complete in second quarter rather than first

Gilead swoops on Forty Seven with $4.9bn all-cash deal

GileadTakeover is latest in a string of billion-plus deals signed by Gilead

Boehringer links up with Trutino for cancer R&D

Collaboration agreement will focus on cytokine treatments

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Gains rights to tau-targeting drug ST-501 as part of broader alliance

Takeda buys coeliac disease partner PvP Biologics after phase 1 win

TakedaDeal includes upfront payment plus up to $330m in milestones

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

COVID-19 Updates and Daily News

Featured jobs


Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...